1Division of Infectious Diseases,Department of Healthcare Epidemiology,Infection Prevention and Control Perelman School of Medicine,University of Pennsylvania,Philadelphia,Pennsylvania.
2Division of Hematology and Oncology,Department of Healthcare Epidemiology,Perelman School of Medicine,University of Pennsylvania,Philadelphia,Pennsylvania.
Infect Control Hosp Epidemiol. 2018 Jul;39(7):863-866. doi: 10.1017/ice.2018.83. Epub 2018 Apr 25.
In a cohort of inpatients with hematologic malignancy and positive enzyme immunoassay (EIA) or polymerase chain reaction (PCR) Clostridium difficile tests, we found that clinical characteristics and outcomes were similar between these groups. The method of testing is unlikely to predict infection in this population, and PCR-positive results should be treated with concern.Infect Control Hosp Epidemiol 2018;863-866.
在一组患有血液恶性肿瘤且酶免疫测定 (EIA) 或聚合酶链反应 (PCR) 艰难梭菌检测阳性的住院患者中,我们发现这些组之间的临床特征和结局相似。检测方法不太可能预测该人群中的感染,并且应该对 PCR 阳性结果给予关注。感染控制与医院流行病学 2018;863-866.